Advertisement
Business Award – April 24, 2025
Leon Wyszkowski, president of analytical services for clinical research, has received the Key to Gothenburg, on behalf of Thermo Fisher during a ceremony at the City Hall.
Intellectual Property – April 23, 2025
The European Patent Office, EPO, has issued a decision to grant European patent for exidavnemab, a drug candidate being developed as a treatment for synucleinopathies such as Parkinson’s disease and Multiple System Atrophy (MSA).
Finland – April 23, 2025
Euro-BioImaging Finland, the research infrastructure of Finnish bioimaging, has received funding of about EUR 28 million from the Research Council of Finland.
Denmark – April 23, 2025
A DKK 200 million grant from the Novo Nordisk Foundation will enable a new national “one point of entry” gateway to health data to be established in Denmark.
Intellectual Property – April 23, 2025
The Unites States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application with claims covering a method of treating rheumatoid arthritis (RA) with resomelagon (AP1189) in combination with methotrexate (MTX).
Biotech Business – April 22, 2025
Zelluna has developed, scaled and automated its manufacturing process for its TCR-NK cell therapies.
Advertisement
Clinical Trials – April 13, 2025
The companies have announced positive in-vivo proof-of-concept data for a powder-based intranasal vaccine candidate formulated with the AmorphOX technology. The data was generated under the collaboration between Orexo and Abera Biosciences entered in December 2024. The aim of the collaboration is to develop mucosal vaccines by combining Orexo’s powder-based drug delivery technology AmorphOX with Abera’s […]
Clinical Trials – April 9, 2025
A new clinical trial map is now accessible from the public website of the Clinical Trials Information System (CTIS).
Clinical Trials – March 25, 2025
Immunovia has announced additional results from the VERIFI study of its next-generation pancreatic cancer test, strengthening the company’s position as it prepares to launch the pancreatic cancer blood test commercially.
Clinical Trials – March 18, 2025
The FDA has approved the company’s IND application to initiate the Phase I/II study Oncorella-1.
Clinical Trials – March 17, 2025
The company has announced the authorization of its Clinical Trial Application (CTA) from the regulatory authorities in four European countries under the European Union’s (EU) harmonised framework, for VIDAR-1, with Germany acting as the reference state.
Clinical Trials – February 28, 2025
Evaxion Biotech will further enhance the data package from its ongoing phase 2 trial with the company’s lead asset EVX-01 by extending the trial from two to three years.
Advertisement
CDMO – April 15, 2025
A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions, has launched with an integrated network across Europe.
Agreement – April 14, 2025
OncoZenge and Avernus Pharma General Trading, a pharma marketing company from the UAE, have signed an exclusive agreement to license BupiZenge for commercialization and distribution in the Gulf Cooperation Council (GCC) region.
Acquisition – April 10, 2025
EQT and KKR has announced that EQT VIII fund has agreed to sell Karo Healthcare to KKR.
Acquisition – April 22, 2025
RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, has announced a recommended public tender offer to the shareholders of Biotage to transfer all of the ordinary shares of Biotage to RWK BidCo for SEK 145 in cash per ordinary share.
Collaboration – April 7, 2025
These partnerships are part of ContextVision’s broader strategy to engage with global ultrasound players, securing additional expertise and analytical support, and to drive advancements in data quality and clinical applications for ultrasound-based solutions.
Acquisition – April 6, 2025
BICO Group has entered into an agreement to divest MatTek Corp and Visikol Inc to Sartorius Lab Holding GmbH for USD 80 million, on a cash and debt-free basis.
Biotech article – April 21, 2025
Oncopeptides has announced the publication of new real-world data (RWD) that further support the effectiveness and tolerability of melflufen, branded in Europe as Pepaxti, in patients with relapsed, refractory multiple myeloma (RRMM).
Biotech Business – April 15, 2025
The European Commission has granted BioArctic’s partner Eisai’s application for Marketing Authorization of Leqembi (lecanemab) in the European Union (EU).
Biotech Business – April 15, 2025
Nykode announces that Michael Engsig, CEO, Agnete Fredriksen, CSO & Co-founder, and Harald Gurvin, CFO, have withdrawn their recent resignations and will continue with Nykode.
Science News – April 9, 2025
A simpler method of analyzing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University.
Science News – April 4, 2025
Researchers at Karolinska Institutet have developed a method that shows how the nervous system and sensory organs are formed in an embryo.
Science News – April 1, 2025
Swedish researchers at Sahlgrenska Academy, University of Gothenburg, have identified genetic variants that increase the risk of atherosclerosis.
Ascendis Pharma
Ascendis Pharma A/S, a U.S. publicly held, Biopharmaceutical company founded in Copenhagen, Denmark in 2007, committed to addressing unmet medical needs within the therapeutic area’s endocrinology and oncology.
Argon Medical Devices
ARGON Medical Devices is a global manufacturer of specialty medical products, headquartered in Plano, Texas. The company offers a broad range of medical devices for Interventional Radiology, Vascular Surgery, Interventional Cardiology and Oncology.
Bioneer
Bioneer is a trusted strategic partner for Biotech and Pharmaceutical companies worldwide. With 40 years of experience, they drive impact in the Life Science ecosystem across the Nordics and globally as a Danish government-approved Research and Technology Organization (RTO).
Orifarm
In Orifarm, they aim to bring healthy days by making modern healthcare a better deal for the people and the societies they serve. Everyone should have access to modern medicine.
Bioneer
Bioneer is a trusted strategic partner for Biotech and Pharmaceutical companies worldwide. With 40 years of experience, they drive impact in the Life Science ecosystem across the Nordics and globally as a Danish government-approved Research and Technology Organization (RTO).
Stryker
As Territory Sales Manager, you will help us deliver on our mission of making healthcare better by promoting and selling Stryker’s Surgical Technologies product portfolio.
In a new job – April 10, 2025
Eva Johnsson brings experience in clinical drug development and medical affairs, including regulatory approvals and drug commercialization.
In a new job – April 9, 2025
Marcella Origgi has been appointed Chief Executive Officer (CEO) of the company’s Helsinki headquarters and Naples subsidiary.
In a new job – April 8, 2025
Dr. Hilja Ibert brings extensive leadership experience in the diagnostics industry and a strong track record of commercial success, states Elypta.
Career choice – April 10, 2025
Hamid Parsa has always wanted to do something that adds value to society and people, and within life sciences he has the opportunity to do just that.
Career choice – March 14, 2025
Charlotte Schönbeck has always been inquisitive and as sales specialist she gets to work with many different life science professionals. She learns something new from all of them by working together through their individual challenges to find the best solution.
Careers article – January 9, 2025
Getting back to work after a long and relaxing holiday can be quite hard. Here is some advice to make things easier.
Profiles in Pharma – April 2, 2025
For Sirpa and Markku Jalkanen of Finland, M.D. and Ph.D., married, immunotherapy researchers, working together came as naturally as a courtship.
Nobel Prize Laureate – December 12, 2024
Victor Ambros, Professor of Molecular Medicine and the Silverman Chair in Natural Sciences at the University of Massachusetts Chan Medical School, is one of this year’s winners of the Nobel Prize in Physiology or Medicine.
Nobel Prize Laureate – December 10, 2024
More than three decades after their discovery of microRNA, Professor Gary Ruvkun received the “mythic call” from Stockholm to learn that he’d been awarded the Nobel Prize in Physiology or Medicine alongside his erstwhile colleague Victor Ambros.
Advertisement
This site uses cookies
